Japan has agreed to buy 150 million doses of Novavax's coronavirus vaccine, with Japanese firm Takeda expecting to manufacture the formula for distribution early next year, the drugmaker said Tuesday.
AFP
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business